(Q44935495)

7 December 2017

Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation (English)

1 reference

7 December 2017

0 references

Todd Brusko

1

1 reference

PubMed ID

18395864

7 December 2017

Jeffrey Bluestone

series ordinal

2

1 reference

PubMed ID

18395864

7 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

European Journal of Immunology

7 December 2017

1 reference

7 December 2017

38

1 reference

7 December 2017

4

1 reference

7 December 2017

931-934

1 reference

Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes

7 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Regulatory T cells in human disease and their potential for therapeutic manipulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Autoimmune Diseases as the Loss of Active “Self‐Control”

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

FOXP3: of mice and men.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Clinical application of expanded CD4+25+ cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Interleukin 2 receptor gene expression in normal human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

"Infectious" transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Humanized mice in translational biomedical research

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Deacetylase inhibition promotes the generation and function of regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Antigen-specific regulatory T cells--ex vivo expansion and therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

CD3-specific antibodies: a portal to the treatment of autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200738108

7 January 2021

Identifiers

DOI

10.1002/EJI.200738108

1 reference

7 December 2017

1 reference

PubMed ID

18395864